Abbott Laboratories (ABT)

$95.40 +3.22 (3.49%)
Market Cap 166.17B
Revenue (ttm) 44.33B
Net Income (ttm) 6.52B
EPS (ttm) N/A
PE Ratio 17.69
Forward PE 16.83
Profit Margin 14.72%
Debt to Equity Ratio 0.65
Volume 10,644,500
Avg Vol 13,299,630
Day's Range N/A - N/A
Shares Out 1.74B
Stochastic %K 96%
Beta 0.61
Analysts Strong Sell
Price Target $117.11

Company Profile

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement ther...

Industry: Medical Devices
Sector: Healthcare
Phone: 224 667 6100
Address:
100 Abbott Park Road, Abbott Park, United States
1212JM
1212JM Jul. 4 at 3:04 PM
$ABT $160 by next 4th of July
0 · Reply
spearnreel
spearnreel Jul. 4 at 2:21 PM
$ABT Med tech trendy on July 4th🇺🇸 $$BSX $ISRG $MDT $IHI
0 · Reply
Broview
Broview Jul. 4 at 1:33 PM
$ABT rebounding starts?
0 · Reply
john565
john565 Jul. 2 at 10:18 PM
$ABT I am about to break even 😅
0 · Reply
otapnow
otapnow Jul. 2 at 5:55 PM
$ABT 95 seems like a big wall. Once it can push past it, 100 will be easy
0 · Reply
xX420StockQuickScoper69X
xX420StockQuickScoper69X Jul. 2 at 5:28 PM
$ABT $NVO July 100% super green for healthcare sector for idek how many years-worth
0 · Reply
DBRGLong
DBRGLong Jul. 2 at 4:53 PM
$TWST completely out of all remaining positions now at $104 earlier this morning, once the potential short squeeze volume appears to have dried up. Have now completely reinvested all proceeds into $ABT at an average cost of $92 a share. Looking forward to a great ride with $ABT through the upcoming soon to be reported earnings, & between now & year-end. Will look to re-enter TWST again some day down the road, once the price corrects & becomes more attractive. Much love to TWST for providing a tremendous well over 200%+ YTD return. Happy 4th of July to all in the meantime! 🥂
1 · Reply
Orbit100
Orbit100 Jul. 2 at 4:30 PM
$ABT Abbott officially launches its PFA catheter nationwide in July. Load up now.
0 · Reply
FundaTech
FundaTech Jul. 2 at 3:30 PM
$ABT
0 · Reply
FundaTech
FundaTech Jul. 2 at 3:17 PM
$ABT Oh, Clever Girl
0 · Reply
Latest News on ABT
Tandem Diabetes launches t:slim X2 compatibility with Abbott’s FreeStyle

2026-07-01T12:41:00.000Z - 3 days ago

Tandem Diabetes launches t:slim X2 compatibility with Abbott’s FreeStyle

TNDM

Abbott initiated with an Outperform at Baird

2026-07-01T09:20:19.000Z - 3 days ago

Abbott initiated with an Outperform at Baird

3 Dividend Aristocrat Stocks Wall Street Loves Right Now — June 30, 2026

2026-06-30T20:47:27.000Z - 3 days ago

3 Dividend Aristocrat Stocks Wall Street Loves Right Now — June 30, 2026

KO NUE

Abbott initiated with an Outperform at Baird

2026-06-30T20:20:43.000Z - 3 days ago

Abbott initiated with an Outperform at Baird

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

Jun 29, 2026, 4:43 PM EDT - 4 days ago

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

ADM APD BAC CMCSA CVS DIS FITB

Prosecutors prepped to charge Abbott, officials opted for settlement, WSJ says

2026-06-29T10:10:23.000Z - 5 days ago

Prosecutors prepped to charge Abbott, officials opted for settlement, WSJ says

US DOJ closes criminal probe into Abbott over baby formula plant, WSJ reports

Jun 28, 2026, 9:17 PM EDT - 5 days ago

US DOJ closes criminal probe into Abbott over baby formula plant, WSJ reports

The Baby Formula Probe Produced a Pile of Evidence. Then the DOJ Dropped the Case.

Jun 28, 2026, 9:00 PM EDT - 5 days ago

The Baby Formula Probe Produced a Pile of Evidence. Then the DOJ Dropped the Case.

3 Dividend Aristocrat Stocks with 20%+ Upside — June 25, 2026

2026-06-25T17:44:45.000Z - 9 days ago

3 Dividend Aristocrat Stocks with 20%+ Upside — June 25, 2026

CTAS MCD

Abbott hosts conference call for second-quarter earnings

Jun 25, 2026, 9:00 AM EDT - 9 days ago

Abbott hosts conference call for second-quarter earnings

Abbott and ALZpath announce license agreement

2026-06-24T12:35:52.000Z - 10 days ago

Abbott and ALZpath announce license agreement

ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease Testing

Jun 24, 2026, 8:30 AM EDT - 10 days ago

ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease Testing

ALZpath signs licensing deal with Abbott to develop Alzheimer's blood test

Jun 24, 2026, 7:36 AM EDT - 10 days ago

ALZpath signs licensing deal with Abbott to develop Alzheimer's blood test

3 Dividend Aristocrat Stocks Wall Street Loves Right Now — June 23, 2026

2026-06-23T22:53:44.000Z - 10 days ago

3 Dividend Aristocrat Stocks Wall Street Loves Right Now — June 23, 2026

NEE WMT

Missouri appeals court won't send Abbott's appeal of $495 million preterm baby formula verdict to higher court

Jun 23, 2026, 1:34 PM EDT - 11 days ago

Missouri appeals court won't send Abbott's appeal of $495 million preterm baby formula verdict to higher court

New Similac® survey finds social media pressure to be "perfect" is fueling a shift toward authenticity for the next generation of parents

Jun 22, 2026, 12:00 PM EDT - 12 days ago

New Similac® survey finds social media pressure to be "perfect" is fueling a shift toward authenticity for the next generation of parents

Living Longer Is Big Business. These Stocks Will Benefit.

Jun 18, 2026, 2:14 PM EDT - 16 days ago

Living Longer Is Big Business. These Stocks Will Benefit.

DXCM GH HIMS PLNT

The Healthcare M&A Wave

Jun 17, 2026, 12:30 PM EDT - 17 days ago

The Healthcare M&A Wave

ALNY AMGN AMRX ANTX AZN BDX BEAM

Citi sum-of-the-parts analysis shows Abbott share upside

2026-06-17T10:57:22.000Z - 17 days ago

Citi sum-of-the-parts analysis shows Abbott share upside

Abbott declares 410th consecutive quarterly dividend

Jun 12, 2026, 2:29 PM EDT - 22 days ago

Abbott declares 410th consecutive quarterly dividend

Abbott price target lowered to $102 from $120 at BofA

2026-06-12T10:41:20.000Z - 22 days ago

Abbott price target lowered to $102 from $120 at BofA

New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired with support from community health workers

Jun 8, 2026, 9:00 AM EDT - 26 days ago

New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired with support from community health workers

Abbott announces new data on DKA for people with Type 1, Type 2 diabetes

2026-06-07T22:10:06.000Z - 26 days ago

Abbott announces new data on DKA for people with Type 1, Type 2 diabetes

The U.S. stock market is facing historic downside risk — these 10 low-volatility stocks can protect your portfolio

Jun 6, 2026, 10:01 AM EDT - 4 weeks ago

The U.S. stock market is facing historic downside risk — these 10 low-volatility stocks can protect your portfolio

GIS KMB MDT O PPL ROP SNA

New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis

Jun 6, 2026, 9:00 AM EDT - 4 weeks ago

New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis

Abbott Labs must face lawsuit over PediaSure children's growth claims

Jun 4, 2026, 3:46 PM EDT - 4 weeks ago

Abbott Labs must face lawsuit over PediaSure children's growth claims

MiniMed announces expanded ketone sensor agreement with Abbott

2026-06-03T11:49:56.000Z - 4 weeks ago

MiniMed announces expanded ketone sensor agreement with Abbott

MMED

Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes

May 27, 2026, 9:00 AM EDT - 5 weeks ago

Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes

ACS guideline reaffirms Abbott leadership in noninvasive colorectal cancer screening

May 27, 2026, 7:01 AM EDT - 5 weeks ago

ACS guideline reaffirms Abbott leadership in noninvasive colorectal cancer screening

Abbott showcases expanding evidence across its cancer diagnostics portfolio at ASCO 2026

May 26, 2026, 9:00 AM EDT - 5 weeks ago

Abbott showcases expanding evidence across its cancer diagnostics portfolio at ASCO 2026

Even a High-Priced Market Has Bargains. 10 Undervalued Blue-Chip Stocks.

May 15, 2026, 1:00 AM EDT - 7 weeks ago

Even a High-Priced Market Has Bargains. 10 Undervalued Blue-Chip Stocks.

ACN DHR HD MCD MDT MKC RSG

Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform

Apr 28, 2026, 9:00 AM EDT - 2 months ago

Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform

Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026

Apr 25, 2026, 12:30 PM EDT - 2 months ago

Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026

New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test

Apr 17, 2026, 3:30 PM EDT - 2 months ago

New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test

Abbott Laboratories Cuts Outlook, Says Mild Flu Season Hurt Sales

Apr 16, 2026, 11:22 AM EDT - 2 months ago

Abbott Laboratories Cuts Outlook, Says Mild Flu Season Hurt Sales

Abbott Laboratories Earnings Call Transcript: Q1 2026

Apr 16, 2026, 9:00 AM EDT - 2 months ago

Abbott Laboratories Earnings Call Transcript: Q1 2026

Abbott Laboratories Earnings release: Q1 2026

Apr 16, 2026, 9:00 AM EDT - 2 months ago

Abbott Laboratories Earnings release: Q1 2026

Abbott Laboratories Slides: Q1 2026

Apr 16, 2026, 9:00 AM EDT - 2 months ago

Abbott Laboratories Slides: Q1 2026

Abbott Laboratories Quarterly report: Q1 2026

Apr 16, 2026, 9:00 AM EDT - 2 months ago

Abbott Laboratories Quarterly report: Q1 2026

Abbott Stock Tumbles on Earnings. Nutrition Business Is Struggling and Merger Costs Are Biting.

Apr 16, 2026, 8:05 AM EDT - 2 months ago

Abbott Stock Tumbles on Earnings. Nutrition Business Is Struggling and Merger Costs Are Biting.

Abbott first-quarter results beat on cancer diagnostics, medical device strength

Apr 16, 2026, 7:33 AM EDT - 2 months ago

Abbott first-quarter results beat on cancer diagnostics, medical device strength

Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences

Apr 16, 2026, 7:30 AM EDT - 2 months ago

Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences

Jury orders Abbott to pay $53 million in preterm infant formula trial, media report says

Apr 9, 2026, 10:16 PM EDT - 3 months ago

Jury orders Abbott to pay $53 million in preterm infant formula trial, media report says

New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health

Apr 9, 2026, 9:00 AM EDT - 3 months ago

New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health

Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR® platform

Mar 30, 2026, 9:00 AM EDT - 3 months ago

Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR® platform

Abbott hosts conference call for first-quarter earnings

Mar 26, 2026, 9:00 AM EDT - 3 months ago

Abbott hosts conference call for first-quarter earnings

John Stamos and Jodie Sweetin reunite for "The (Second) Talk" with Cologuard® tests, encouraging colon cancer screening

Mar 24, 2026, 8:00 AM EDT - 3 months ago

John Stamos and Jodie Sweetin reunite for "The (Second) Talk" with Cologuard® tests, encouraging colon cancer screening

Abbott completes acquisition of Exact Sciences

Mar 23, 2026, 8:50 AM EDT - 3 months ago

Abbott completes acquisition of Exact Sciences

Abbott acquisition of Exact Sciences set to close on March 23, 2026

Mar 20, 2026, 9:00 AM EDT - 3 months ago

Abbott acquisition of Exact Sciences set to close on March 23, 2026

Pivot Bio CEO Chris Abbott to Present at World Agri-Tech Innovation Summit

Mar 13, 2026, 2:17 PM EDT - 4 months ago

Pivot Bio CEO Chris Abbott to Present at World Agri-Tech Innovation Summit

Abbott Laboratories Proxy statement: Proxy Filing

Mar 13, 2026, 8:00 AM EDT - 4 months ago

Abbott Laboratories Proxy statement: Proxy Filing

Abbott Laboratories Proxy statement: Proxy Filing

Mar 13, 2026, 8:00 AM EDT - 4 months ago

Abbott Laboratories Proxy statement: Proxy Filing

Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management

Mar 12, 2026, 8:00 AM EDT - 4 months ago

Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management

Exact Sciences Stockholders Approve Acquisition by Abbott

Feb 20, 2026, 4:05 PM EST - 4 months ago

Exact Sciences Stockholders Approve Acquisition by Abbott

EXAS

Abbott declares 409th consecutive quarterly dividend

Feb 20, 2026, 11:38 AM EST - 4 months ago

Abbott declares 409th consecutive quarterly dividend

Carl Abbott's “House of Columns” Brings Sarasota School Modernism to the Market on Longboat Key

Feb 17, 2026, 11:32 AM EST - 4 months ago

Carl Abbott's “House of Columns” Brings Sarasota School Modernism to the Market on Longboat Key

These 32 favorite stocks signal the bull market is running on fumes

Feb 12, 2026, 8:05 AM EST - 5 months ago

These 32 favorite stocks signal the bull market is running on fumes

AAPL ADBE AMGN AVGO BAC BMY COF

Late-breaking data presentations showcase the safety and efficacy of Abbott's ablation catheters to treat people with atrial fibrillation

Feb 6, 2026, 8:00 AM EST - 5 months ago

Late-breaking data presentations showcase the safety and efficacy of Abbott's ablation catheters to treat people with atrial fibrillation

Abbott recalls glucose sensors after seven deaths linked to faulty readings

Feb 4, 2026, 10:49 AM EST - 5 months ago

Abbott recalls glucose sensors after seven deaths linked to faulty readings

Is The Fall In Abbott Stock Justified?

Jan 23, 2026, 9:35 AM EST - 5 months ago

Is The Fall In Abbott Stock Justified?

Abbott faces India scrutiny in cough syrup abuse investigation, documents show

Jan 23, 2026, 6:43 AM EST - 5 months ago

Abbott faces India scrutiny in cough syrup abuse investigation, documents show

Abbott Laboratories Raised Prices, Prompting Sales Slump

Jan 22, 2026, 2:31 PM EST - 5 months ago

Abbott Laboratories Raised Prices, Prompting Sales Slump

MRNA Rallies on Cancer Vaccine Trial, PG Mixed Earnings, ABT Sell-Off

Jan 22, 2026, 11:00 AM EST - 5 months ago

MRNA Rallies on Cancer Vaccine Trial, PG Mixed Earnings, ABT Sell-Off

MRNA PG

Cramer's Mad Dash: Abbott Labs

Jan 22, 2026, 9:53 AM EST - 5 months ago

Cramer's Mad Dash: Abbott Labs

Abbott Laboratories Earnings Call Transcript: Q4 2025

Jan 22, 2026, 9:00 AM EST - 5 months ago

Abbott Laboratories Earnings Call Transcript: Q4 2025

Abbott Laboratories Annual report: Q4 2025

Jan 22, 2026, 9:00 AM EST - 5 months ago

Abbott Laboratories Annual report: Q4 2025

Abbott Laboratories Earnings release: Q4 2025

Jan 22, 2026, 9:00 AM EST - 5 months ago

Abbott Laboratories Earnings release: Q4 2025

Abbott Laboratories Slides: Q4 2025

Jan 22, 2026, 9:00 AM EST - 5 months ago

Abbott Laboratories Slides: Q4 2025

Abbott Stock Slumps on Earnings. What's Weighing on the Medical Devices Maker.

Jan 22, 2026, 7:49 AM EST - 5 months ago

Abbott Stock Slumps on Earnings. What's Weighing on the Medical Devices Maker.

Abbott misses quarterly revenue estimates on weakness in diagnostics segment

Jan 22, 2026, 7:34 AM EST - 5 months ago

Abbott misses quarterly revenue estimates on weakness in diagnostics segment

Abbott Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Financial Outlook

Jan 22, 2026, 7:30 AM EST - 5 months ago

Abbott Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Financial Outlook

Abbott receives CE Mark for the TactiFlex™ Duo Ablation Catheter to treat patients with abnormal heart rhythms

Jan 20, 2026, 9:00 AM EST - 5 months ago

Abbott receives CE Mark for the TactiFlex™ Duo Ablation Catheter to treat patients with abnormal heart rhythms

1212JM
1212JM Jul. 4 at 3:04 PM
$ABT $160 by next 4th of July
0 · Reply
spearnreel
spearnreel Jul. 4 at 2:21 PM
$ABT Med tech trendy on July 4th🇺🇸 $$BSX $ISRG $MDT $IHI
0 · Reply
Broview
Broview Jul. 4 at 1:33 PM
$ABT rebounding starts?
0 · Reply
john565
john565 Jul. 2 at 10:18 PM
$ABT I am about to break even 😅
0 · Reply
otapnow
otapnow Jul. 2 at 5:55 PM
$ABT 95 seems like a big wall. Once it can push past it, 100 will be easy
0 · Reply
xX420StockQuickScoper69X
xX420StockQuickScoper69X Jul. 2 at 5:28 PM
$ABT $NVO July 100% super green for healthcare sector for idek how many years-worth
0 · Reply
DBRGLong
DBRGLong Jul. 2 at 4:53 PM
$TWST completely out of all remaining positions now at $104 earlier this morning, once the potential short squeeze volume appears to have dried up. Have now completely reinvested all proceeds into $ABT at an average cost of $92 a share. Looking forward to a great ride with $ABT through the upcoming soon to be reported earnings, & between now & year-end. Will look to re-enter TWST again some day down the road, once the price corrects & becomes more attractive. Much love to TWST for providing a tremendous well over 200%+ YTD return. Happy 4th of July to all in the meantime! 🥂
1 · Reply
Orbit100
Orbit100 Jul. 2 at 4:30 PM
$ABT Abbott officially launches its PFA catheter nationwide in July. Load up now.
0 · Reply
FundaTech
FundaTech Jul. 2 at 3:30 PM
$ABT
0 · Reply
FundaTech
FundaTech Jul. 2 at 3:17 PM
$ABT Oh, Clever Girl
0 · Reply
FundaTech
FundaTech Jul. 1 at 4:38 PM
$ABT You may try, but it will go higher instead
0 · Reply
FundaTech
FundaTech Jul. 1 at 3:23 PM
$ABT Likely to close at 94.50 imo
0 · Reply
FundaTech
FundaTech Jul. 1 at 2:22 PM
$ABT Baby got Back
0 · Reply
spearnreel
spearnreel Jul. 1 at 8:09 AM
$BSX Trading superficially cheap to peers in the entirety of the $IHI basket $ISRG $MDT $ABT This is where you place the bet that something internally is wavering or that market manipulation is under construction. Major bundles are loss or made under these exact circumstances. It’s the fear of the trade point right here. The fear of losing an unrecoverable amount of investment or the fear of hearing your spouse indicate yet again, “why do we pay so much income tax.”
0 · Reply
Slippery_Steve
Slippery_Steve Jul. 1 at 2:44 AM
$BSX $IHI $XLV $ABT $MDT What about other .06% , where is the conviction,
0 · Reply
NasdaqFrontier
NasdaqFrontier Jun. 30 at 11:20 PM
$ABT has been getting renewed momentum as sentiment rotates back into smaller narrative-driven names. Moves like this are often driven more by liquidity and attention cycles than fundamentals alone, especially in lower-cap, high-volatility setups. While price action can look strong in short bursts, sustainability ultimately depends on whether real adoption and consistent execution follow the narrative expansion. In these kinds of names, momentum and fundamentals often diverge before converging again later.
0 · Reply
FundaTech
FundaTech Jun. 30 at 7:28 PM
$ABT WHY YOU NO LOVE ME ABBOTT
0 · Reply
Thamb19
Thamb19 Jun. 30 at 7:06 PM
$BSX I know what I am doing... $IHI $XLV $ABT $MDT
2 · Reply
Thamb19
Thamb19 Jun. 30 at 6:15 PM
$BSX bring the price down and buy it up? $IHI $XLV $ABT $MDT
0 · Reply
FutureCapitall
FutureCapitall Jun. 30 at 5:23 PM
$ABT is still grinding inside a tight range, no real expansion in either direction. Price action is quiet, more chop than trend, so I’m not overthinking it here. Staying patient and letting the tape show its hand. Above 114 could open room for continuation, while a break below 112.50 would shift the structure and force a reassessment. Until then, it’s just noise and time.
0 · Reply
FundaTech
FundaTech Jun. 30 at 5:12 PM
$ABT $BSX $MDT Why are these so juicy? Ready to launch!!!!
0 · Reply
Thamb19
Thamb19 Jun. 30 at 4:09 PM
$BSX $IHI $ABT $MDT will bounce when $SPY hits this level and reverses
0 · Reply